Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-06-01
著者
-
Yamaguchi Yuko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
SAITO Takeshi
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
USUI Noriko
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
DOBASHI Nobuaki
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
OSAWA Hiroshi
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
TAKAHARA Shinobu
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
Uoshima Nobuhiko
京都府立医科大学 血液･腫瘍内科学
-
Uoshima Nobuhiko
Matsushita Memorial Hospital Moriguchi Jpn
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Usui Noriko
Jikei University Hospital
-
DOBASHI Nobuaki
Jikei University Hospital
-
Dobashi Nobuaki
東京慈恵会医科大学 内科学(血液･腫瘍)
-
Dobashi Nobuaki
Department Of Clinical Oncology And Hematology School Of Medicine The Jikei University
-
Dobashi Nobuaki
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Usui N
Jikei University Hospital
-
Minami Jiro
東京慈恵会医科大学 内科学(血液･腫瘍)
-
Minami Jiro
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Asai Osamu
Department Of Clinical Oncology And Hematology School Of Medicine The Jikei University
-
Takei Yutaka
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Yahagi Yuichi
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Shimada Takaki
Divesion Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Ogasawara Yoji
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Osawa Hiroshi
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
ASAI Osamu
Oncology, Department of Internal Medicine, Jikei University School of Medicine
-
YANO Shingo
Oncology, Department of Internal Medicine, Jikei University School of Medicine
-
TAKEI Yutaka
Oncology, Department of Internal Medicine, Jikei University School of Medicine
-
OGASAWARA Yoji
Oncology, Department of Internal Medicine, Jikei University School of Medicine
-
MINAMI Jiro
Oncology, Department of Internal Medicine, Jikei University School of Medicine
-
Usui Noriko
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Asai Osamu
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Dobashi Nobuaki
Jikei Univ. Hospital Tokyo Jpn
-
Takahara Shinobu
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Sekita Toru
Department Of Internal Medicine (ii) Jikei University School Of Medicine
-
Yano Shingo
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Usui Noriko
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Minami Jiro
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Takahara Shinobu
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Osawa Hiroshi
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Ogasawara Yoji
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Yano Shingo
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Asai Osamu
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Yamaguchi Yuko
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Takei Yutaka
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Saito Takeshi
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Sasaki T
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Osawa Hiroshi
Division Of Cardiovascular Surgery Shimada General Hospital
-
DOBASHI Nobuaki
Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine
-
SAITO Takeshi
Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF)
- Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
- Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
- Severe Aplastic Anemia Associated With Chronic Natural Killer Cell Lymphocytosis
- Cardiac Lesions Leading to Sudden Death in a Beagle
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Case-control study of leukemia and diagnostic radiation exposure
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Expression of Human Tumor-Associated Antigen RCAS1 in Adult T-Cell Leukemia/Lymphoma
- A chronic myelogenous leukemia-like myeloproliferative disorder accompanied by T-cell lymphoblastic lymphoma with chromosome translocation t(8;13) (p11;q12): a Japanese case
- Sweet's syndrome followed by retinoic acid syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- X-Linked Lymphoproliferative Disease in an Adult
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma
- Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia
- All-trans-retinoic acid as a possible cause of acute pancreatitis even in the absence of hypertriglyceridemia
- Prevalence and Clinical Characteristics of Acute Myeloid Leukemia Associated with Disseminated Intravascular Coagulation
- Successful Reduced-Intensity Stem Cell Transplantation from an HLA Haploidentical 3-Loci-Mismatched Donor on the Basis of Fetomaternal Microchimerism in a Patient with Advanced Acute Myeloid Leukemia
- Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
- Successful Combination Therapy with Trastuzumab and Paclitaxel for Adriamycin- and Docetaxel-Resistant Inflammatory Breast Cancer
- Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma
- Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients
- Gene Expression of Erythropoietin in Renal Cell Carcinoma
- Carcinoembryonic Antigen-Producing Multiple Myeloma Detected by a Transcription-Reverse Transcription Concerted Reaction System
- Toxicity and Outcome of Intensive Chemotherapy for Acute Lymphoblastic Leukemia Complicated with Turner's Syndrome
- CD2^+ Tetraploid Acute Promyelocytic Leukemia Variant with Double (15 ; 17) Translocations
- Septic Intramuscular Embolism in a Neutropenic Patient with Myelodysplastic Syndrome Accompanied by Asymptomatic Septic Pulmonary Emboli
- Th1/Th2 Lymphocyte Balance in Patients with Aplastic Anemia
- Successful Immunosuppressive Therapy with Cyclosporine A for Posthepatitis B-Cell Deficiency With Activated Cytoplasmic Interferon-γ-Positive T-Lymphocytes
- Monitoring Minimal Residual Disease in Patients With MLL-AF6 Fusion Transcript-Positive Acute Myeloid leukemia Fllowing Allogeneic Bone Marrow Transplantation
- Renal vein lymphoma embolism in non-Hodgkin lymphoma
- Superior sagital sinus thrombosis in a patient with aplastic anemia treated with anabolic steroids
- Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Efficient Production of Adeno-associated Virus Vectors Using Split-type Helper Plasmids
- Fas and Mutant Estrogen Receptor Chimeric Gene: A Novel Suicide Vector for Tamoxifen-inducible Apoptosis
- Defensins act as potent adjuvants that promote cellular and hmoral immune responses in mice to a Iymphoma idiotype and carrier antigens
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Two Cases of Mediastinal Gray Zone Lymphoma
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies : analysis of eight patients
- Potential macrophage-T progenitor origin of systemic anaplastic large cell lymphoma
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Off-pump coronary artery bypass grafting with an aortic nonclamping technique may reduce the incidence of cerebral complications
- Cardiac Lesions Leading to Sudden Death in a Beagle
- Improvement of Crystallographic Quality of Electroplated Copper Thin-Film Interconnections for Through-Silicon Vias
- Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin